Invasive breast carcinoma - IARC

1197. Herod JJ, Shafi MI, Rollason TP,
Jordan JA, Luesley DM (1996). Vulvar
intraepithelial neoplasia with superficially
invasive carcinoma of the vulva. Br J
Obstet Gynaecol 103: 453-456.
1198. Herrera LJ, Lugo-Vicente H (1998).
Primary embryonal rhabdomyosarcoma of
the breast in an adolescent female: a case
report. J Pediatr Surg 33: 1582-1584.
1199. Herrero R, Munoz N (1999). Human
papillomavirus and cancer. Cancer surv
33: 75-98.
1200. Herrington CS, Tarin D, Buley I,
Athanasou N (1994). Osteosarcomatous
differentiation in carcinoma of the breast:
a case of 'metaplastic' carcinoma with
osteoclasts and osteoclast-like giant cells.
Histopathology 24: 282-285.
1201. Herrington CS, Wells M (2002).
Premalignant and malignant squamous
lesions of the cervix. In: Haines and Taylor
Obstetrical and Gynaecological Pathology.
H Fox, M Wells (Eds.) Fifth ed. Churchill
Livingstone: Edinburgh, pp. 297-338.
1202. Hertel BF, Zaloudek C, Kempson RL
(1976). Breast adenomas. Cancer 37: 2891-
2905.
1203. Hertig AT, Mansell H (1956). Tumours
of the female sex organs. Part I
Hydatidiform mole and choriocarcinoma.
In: Atlas of Tumour Pathology, AFIP (Ed.)
AFIP: Washington,DC.
1204. Hessler C, Schnyder P, Ozzello L
(1978). Hamartoma of the breast: diagnostic
observation of 16 cases. Radiology 126:
95-98.
1205. Hetzel DJ, Wilson TO, Keeney GL,
Roche PC, Cha SS, Podratz KC (1992). HER-
2/neu expression: a major prognostic factor
in endometrial cancer. Gynecol Oncol
47: 179-185.
1206. Heywang-Kobrunner SH, Dershaw
DD, Schreer I (2000). Diagnostic Breast
Imaging. 2nd ed. Thieme: New York.
1207. Hibberd AD, Horwood LJ, Wells JE
(1983). Long term prognosis of women with
breast cancer in New Zealand: study of
survival to 30 years. Br Med J (Clin Res Ed)
286: 1777-1779.
1208. Hidalgo A, Schewe C, Petersen S,
Salcedo M, Gariglio P, Schluns K, Dietel M,
Petersen I (2000). Human papilloma virus
status and chromosomal imbalances in
primary cervical carcinomas and tumour
cell lines. Eur J Cancer 36: 542-548.
1209. Hierro I, Blanes A, Matilla A, Munoz
S, Vicioso L, Nogales FF (2000). Merkel cell
(neuroendocrine) carcinoma of the vulva.
A case report with immunohistochemical
and ultrastructural findings and review of
the literature. Pathol Res Pract 196: 503-
509.
1210. Hill A, Yagmur Y, Tran KN, Bolton JS,
Robson M, Borgen PI (1999). Localized
male breast carcinoma and family history.
An analysis of 142 patients. Cancer 86:
821-825.
1211. Hill RP, Miller FN (1954). With case
report of carcinomatous transformation in
an adenoma. Cancer 7: 318-324.
1212. Hinkula M, Pukkala E, Kyyronen P,
Kauppila A (2002). Grand multiparity and
incidence of endometrial cancer: a population-based
study in Finland. Int J Cancer
98: 912-915.
1213. Hiort O, Naber SP, Lehners A,
Muletta-Feurer S, Sinnecker GH, Zollner A,
Komminoth P (1996). The role of androgen
receptor gene mutations in male breast
carcinoma. J Clin Endocrinol Metab 81:
3404-3407.
1214. Hirakawa T, Tsuneyoshi M, Enjoji M
(1989). Squamous cell carcinoma arising in
mature cystic teratoma of the ovary.
Clinicopathologic and topographic analysis.
Am J Surg Pathol 13: 397-405.
1215. Hirakawa T, Tsuneyoshi M, Enjoji M,
Shigyo R (1988). Ovarian sarcoma with histologic
features of telangiectatic osteosarcoma
of the bone. Am J Surg Pathol 12:
567-572.
1216. Hirano A, Emi M, Tsuneizumi M,
Utada Y, Yoshimoto M, Kasumi F, Akiyama
F, Sakamoto G, Haga S, Kajiwara T,
Nakamura Y (2001). Allelic losses of loci at
3p25.1, 8p22, 13q12, 17p13.3, and 22q13 correlate
with postoperative recurrence in
breast cancer. Clin Cancer Res 7: 876-882.
1217. Hirohashi S (1998). Inactivation of the
E-cadherin-mediated cell adhesion system
in human cancers. Am J Pathol 153: 333-
339.
1218. Hiroi H, Yasugi T, Matsumoto K, Fujii
T, Watanabe T, Yoshikawa H, Taketani Y
(2001). Mucinous adenocarcinoma arising
in a neovagina using the sigmoid colon
thirty years after operation: a case report.
J Surg Oncol 77: 61-64.
1219. Hislop TG, Elwood JM, Coldman AJ,
Spinelli JJ, Worth AJ, Ellison LG (1984).
Second primary cancers of the breast:
incidence and risk factors. Br J Cancer 49:
79-85.
1220. Hitchcock CL, Norris HJ (1992). Flow
cytometric analysis of endometrial stromal
sarcoma. Am J Clin Pathol 97: 267-271.
1221. Hittmair AP, Lininger RA, Tavassoli
FA (1998). Ductal carcinoma in situ (DCIS)
in the male breast: a morphologic study of
84 cases of pure DCIS and 30 cases of
DCIS associated with invasive carcinoma-
-a preliminary report. Cancer 83: 2139-
2149.
1222. Ho YB, Robertson DI, Clement PB,
Mincey EK (1982). Sclerosing stromal
tumor of the ovary. Obstet Gynecol 60: 252-
256.
1223. Hock YL, Mohamid W (1995). Myxoid
neurofibroma of the male breast: fine needle
aspiration cytodiagnosis. C y t o p a t h o l o g y
6: 44-47.
1224. Hocking GR, Hayman JA, Östör AG
(1996). Adenocarcinoma in situ of the uterine
cervix progressing to invasive adenocarcinoma.
Aust N Z J Obstet Gynaecol 36:
218-220.
1225. Hoda SA, Cranor ML, Rosen PP
(1992). Hemangiomas of the breast with
atypical histological features. Further
analysis of histological subtypes confirming
their benign character. Am J Surg
Pathol 16: 553-560.
1226. Hoda SA, Prasad ML, Moore A, Hoda
RS, Giri D (1999). Microinvasive carcinoma
of the breast: can it be diagnosed reliably
and is it clinically significant? H i s t o -
pathology 35: 468-470.
1227. Hodak E, Jones RE, Ackerman AB
(1993). Solitary keratoacanthoma is a
squamous-cell carcinoma: three examples
with metastases. Am J Dermatopathol 15:
332-342.
1228. Hoerl HD, Hart WR (1998). Primary
ovarian mucinous cystadenocarcinomas:
a clinicopathologic study of 49 cases with
long-term follow-up. Am J Surg Pathol 22:
1449-1462.
1229. Hogervorst FB, Nederlof PM, Gille JJ,
McElgunn CJ, Grippeling M, Pruntel R,
Regnerus R, van Welsem T, van
Spaendonk R, Menko FH, Kluijt I,
Dommering C, Verhoef S, Schouten JP,
van't Veer LJ, Pals G (2003). Large genomic
deletions and duplications in the BRCA1
gene identified by a novel quantitative
method. Cancer Res 63: 1449-1453.
1230. Holland R, Faverly D (1997). Whole
organ studies. In: Ductal Carcinoma in Situ
of the Breast. MJ Silverstein (Ed.) Williams
& Wilkins: Baltimore. pp. 233-240.
1230a. Holland R, Faverly D (1997). The
local distribution of ductal carcinoma in
situ of the breast. In: Ductal Carcinoma in
Situ of the Breast. MJ Silverstein (Ed.)
Williams & Wilkins: Baltimore. pp. 233-240.
1231. Holland R, Hendriks JH (1994).
Microcalcifications associated with ductal
carcinoma in situ: mammographic-pathologic
correlation. Semin Diagn Pathol 11:
181-192.
1232. Hollingsworth HC, Steinberg SM,
Silverberg SG, Merino MJ (1996).
Advanced stage transitional cell carcinoma
of the ovary. Hum Pathol 27: 1267-1272.
1233. Holmberg L, Adami HO, Ekbom A,
Bergstrom R, Sandstrom A, Lindgren A
(1988). Prognosis in bilateral breast cancer.
Effects of time interval between first
and second primary tumours. Br J Cancer
58: 191-194.
1234. Holway AH, Rieger-Christ KM, Miner
WR, Cain JW, Dugan JM, Pezza JA,
Silverman ML, Shapter A, McLellan R,
Summerhayes IC (2000). Somatic mutation
of PTEN in vulvar cancer. Clin Cancer Res
6: 3228-3235.
1235. Homesley HD, Bundy BN, Sedlis A,
Yordan E, Berek JS, Jahshan A, Mortel R
(1993). Prognostic factors for groin node
metastasis in squamous cell carcinoma of
the vulva (a Gynecologic Oncology Group
study). Gynecol Oncol 49: 279-283.
1236. Honore LH, Nickerson KG (1976).
Papillary serous cystadenoma arising in a
paramesonephric cyst of the parovarium.
Am J Obstet Gynecol 125: 870-871.
1237. Hopkins M, Nunez C, Murphy JR,
Wentz WB (1985). Malignant placental site
trophoblastic tumor. Obstet Gynecol 66:
95S-100S.
1238. Hopper JL, Carlin JB (1992). Familial
aggregation of a disease consequent upon
correlation between relatives in a risk factor
measured on a continuous scale. Am J
Epidemiol 136: 1138-1147.
1239. Horie Y, Ikawa S, Kadowaki K,
Minagawa Y, Kigawa J, Terakawa N
(1995). Lipoadenofibroma of the uterine
corpus. Report of a new variant of adenofibroma
(benign mullerian mixed tumor).
Arch Pathol Lab Med 119: 274-276.
1240. Horn LC, Einenkel J, Baier D (2000).
Endometrial metastasis from breast cancer
in a patient receiving tamoxifen therapy.
Gynecol Obstet Invest 50: 136-138.
1241. Horn PL, Thompson WD (1988). Risk
of contralateral breast cancer. A s s o-
ciations with histologic, clinical, and therapeutic
factors. Cancer 62: 412-424.
1242. Horn T, Jao W, Keh PC (1983). Benign
cystic teratoma of the fallopian tube. Arch
Pathol Lab Med 107: 48.
1243. Horne CH, Reid IN, Milne GD (1976).
Prognostic significance of inappropriate
production of pregnancy proteins by
breast cancers. Lancet 2: 279-282.
1244. Horsfall DJ, Tilley WD, Orell SR,
Marshall VR, Cant EL (1986). Relationship
between ploidy and steroid hormone
receptors in primary invasive breast cancer.
Br J Cancer 53: 23-28.
1245. Houghton CR, Iversen T (1982).
Squamous cell carcinoma of the vagina: a
clinical study of the location of the tumor.
Gynecol Oncol 13: 365-372.
1246. Houlston RS, McCarter E, Parbhoo S,
Scurr JH, Slack J (1992). Family history and
risk of breast cancer. J Med Genet 29: 154-
157.
1247. Houvras Y, Benezra M, Zhang H,
Manfredi JJ, Weber BL, Licht JD (2000).
BRCA1 physically and functionally interacts
with ATF1. J Biol Chem 275: 36230-
36237.
1248. Howarth CB, Caces JN, Pratt CB
(1980). Breast metastases in children with
rhabdomyosarcoma. Cancer 46: 2520-2524.
1249. Howat AJ, Armour A, Ellis IO (2000).
Microinvasive lobular carcinoma of the
breast. Histopathology 37: 477-478.
1250. Howe JR, Bair JL, Sayed MG,
Anderson ME, Mitros FA, Petersen GM,
Velculescu VE, Traverso G, Vogelstein B
(2001). Germline mutations of the gene
encoding bone morphogenetic protein
receptor 1A in juvenile polyposis. N a t
Genet 28: 184-187.
1251. Howlett NG, Taniguchi T, Olson S,
Cox B, Waisfisz Q, Die-Smulders C, Persky
N, Grompe M, Joenje H, Pals G, Ikeda H,
Fox EA, D'Andrea AD (2002). Biallelic inactivation
of BRCA2 in Fanconi anemia.
Science 297: 606-609.
1252. Hrynchak M, Horsman D, Salski C,
Berean K, Benedet JL (1994). Complex
karyotypic alterations in an endometrial
stromal sarcoma. Cancer Genet Cytogenet
77: 45-49.
1253. Hsing AW, McLaughlin JK, Cocco P,
Co Chien HT, Fraumeni JFJr. (1998). Risk
factors for male breast cancer (United
States). Cancer Causes Control 9: 269-275.
1254. Hsu SM, Raine L, Nayak RN (1981).
Medullary carcinoma of breast: an
immunohistochemical study of its lymphoid
stroma. Cancer 48: 1368-1376.
1255. Hsueh S, Chang TC (1996). Malignant
rhabdoid tumor of the uterine corpus.
Gynecol Oncol 61: 142-146.
1256. Hu CY, Taymor ML, Hertig AT (1950).
Primary carcinoma of the fallopian tube.
Am J Obstet Gynecol 59: 58-60.
1257. Huang E, Cheng SH, Dressman H,
Pittman J, Tsou MH, Horng CF, Bild A,
Iversen ES, Liao M, Chen CM, West M,
Nevins JR, Huang AT (2003). Gene expression
predictors of breast cancer outcomes.
Lancet 361: 1590-1596.
1258. Huang KT, Chen CA, Cheng WF, Wu
CC, Jou HJ, Hsieh CY, Lin GJ, Hsieh FJ
(1996). Sonographic characteristics of
adenofibroma of the endometrium following
tamoxifen therapy for breast cancer:
two case reports. Ultrasound Obstet
Gynecol 7: 363-366.
1259. Huang LW, Garrett AP, Schorge JO,
Muto MG, Bell DA, Welch WR, Berkowitz
RS, Mok SC (2000). Distinct allelic loss patterns
in papillary serous carcinoma of the
peritoneum. Am J Clin Pathol 114: 93-99.
1260. Huettner PC, Gersell DJ (1994).
Placental site nodule: a clinicopathologic
study of 38 cases. Int J Gynecol Pathol 1 3:
191-198.
1261. Hugh JC, Jackson FI, Hanson J,
Poppema S (1990). Primary breast lymphoma.
An immunohistologic study of 20
new cases. Cancer 66: 2602-2611.
References 391